|
Volumn 38, Issue 12, 2011, Pages 1942-1944
|
[Peptide vaccine therapy with TLR-9 agonist for patients with esophageal squamous cell carcinoma].
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CANCER VACCINE;
CPG OLIGONUCLEOTIDE;
CPG-OLIGONUCLEOTIDE;
IMMUNOLOGICAL ADJUVANT;
OLIGODEOXYRIBONUCLEOTIDE;
SUBUNIT VACCINE;
TLR9 PROTEIN, HUMAN;
TOLL LIKE RECEPTOR 9;
ACTIVE IMMUNIZATION;
ARTICLE;
CLINICAL TRIAL;
DRUG POTENTIATION;
ESOPHAGUS TUMOR;
HUMAN;
IMMUNOLOGY;
PHASE 1 CLINICAL TRIAL;
SQUAMOUS CELL CARCINOMA;
ADJUVANTS, IMMUNOLOGIC;
CANCER VACCINES;
CARCINOMA, SQUAMOUS CELL;
ESOPHAGEAL NEOPLASMS;
HUMANS;
IMMUNOTHERAPY, ACTIVE;
OLIGODEOXYRIBONUCLEOTIDES;
TOLL-LIKE RECEPTOR 9;
VACCINES, SUBUNIT;
|
EID: 84858834795
PISSN: 03850684
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (4)
|
References (0)
|